THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

SSI INVESTMENT MANAGEMENT LLC's Holding History (CIK: 0000938487)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 1,750,000 Value ($000) $1,658 Avg Close — Range —
Q1 2021
Shares 1,750,000 Value ($000) $1,772 Avg Close — Range —
Q4 2020
Shares 1,750,000 Value ($000) $1,648 Avg Close — Range —
Q3 2020
Shares 1,200,000 Value ($000) $1,050 Avg Close — Range —
Q2 2020
Shares 1,200,000 Value ($000) $1,156 Avg Close — Range —
Q1 2020
Shares 2,440,000 Value ($000) $2,343 Avg Close — Range —
Q4 2019
Shares 2,440,000 Value ($000) $2,527 Avg Close — Range —
Q3 2019
Shares 2,250,000 Value ($000) $2,076 Avg Close — Range —
Q2 2019
Shares 2,750,000 Value ($000) $2,376 Avg Close — Range —
Q1 2019
Shares 2,763,000 Value ($000) $2,676 Avg Close — Range —
Q4 2018
Shares 3,007,000 Value ($000) $3,094 Avg Close — Range —
Q3 2018
Shares 3,007,000 Value ($000) $3,541 Avg Close — Range —
Q2 2018
Shares 3,007,000 Value ($000) $2,939 Avg Close — Range —
Q1 2018
Shares 3,007,000 Value ($000) $3,042 Avg Close — Range —
Q4 2017
Shares 3,007,000 Value ($000) $3,283 Avg Close — Range —
Q3 2017
Shares 3,007,000 Value ($000) $3,683 Avg Close — Range —
Q2 2017
Shares 3,007,000 Value ($000) $4,055 Avg Close — Range —
Q1 2017
Shares 3,007,000 Value ($000) $3,802 Avg Close — Range —
Q4 2016
Shares 2,000,000 Value ($000) $2,295 Avg Close — Range —